OPD, a major cause of morbidity and mortality worldwide, 1 is believed to result from an abnormal pulmonary infl ammatory response to noxious particles or gases. 2 Clinically, the disease is defi ned by GOLD (Global Initiative for the Obstructive Lung Disease) as the presence of airway obstruction determined by a postbronchodilator FEV 1 /FVC , 0.70. Although emphysema is not part of the defi nition, the GOLD report does mention chronic airway disease and emphysema as different components of COPD, with varying degrees of each in individual patients. 2 Emphysema is anatomically defi ned as an abnormal permanent enlargement of the airspace distal to the terminal bronchioles, accompanied by destruction of their walls without obvious fi brosis. 
Linda, California) were determined following American Thoracic Society recommendations. 14 The European Community Lung Health Survey values were used as reference. 15 The 6-min walking distance (6MWD) was performed following current American Thoracic Society guidelines. 16 Dyspnea was assessed using the Modifi ed Medical Research Council Dyspnea Scale (MMRC). 17 BMI was calculated as the weight in kilograms divided by height in meters. 2 Inspiratory capacity (IC) was measured as previously described. 18 The ratio between IC and total lung capacity (TLC) was determined from the lung volume measurements. The BODE index (BMI, obstruction, dyspnea, and exercise capacity) was measured and staged in quartiles as previously published by Celli et al. 19 To determine the health-related quality of life we used the Spanish validated version of the St. George Respiratory Questionnaire. 20 An exacerbation was defi ned following the definition by Rodriguez-Roisin, 21 and exacerbation frequency was evaluated by patient recall over the previous year.
CT Scan Evaluation
All participants underwent single breath-hold helical CT scan examination of the chest at end-full-inspiration using a 64-row multidetector scanner (Somatom Sensation 64; Siemens Healthcare; Erlangen, Germany) with low-dose CT scan parameters (120 kVp, 40 mAs), 0.33s rotation time, 1.3 pitch, 32 3 0.6 mm detector collimation, and 64 3 0.6 mm slice acquisition by means of z-fl ying focal spot. 22 The CT scanner was calibrated periodically by standard methods. Slices were obtained contiguously from the thoracic inlet to the adrenal glands without the use of IV contrast material. From the raw data, 1-mm-thick sections were reconstructed using a soft tissue algorithm kernel (B40f). All CT images were transferred to a satellite console (Leonardo; Siemens Healthcare) for quantitative analysis of lung attenuation.
Quantifi cation of Emphysema
Low-dose CT scan examinations were reviewed by the study radiologists (G. B., R. S. M.) blinded to patients' clinical data and spirometry results. Images were segmented using a threedimensional automated image-processing software program (Lung Parenchyma Analysis; Siemens Healthcare; Erlangen, Germany). 23 After initial three-dimensional segmentation of the lung, this program automatically detects the lung contours and the airways based on threshold values and anatomic knowledge-based algorithm without the need for manual interaction. For emphysema detection, a threshold value of 2 960 Hounsfi eld Units (HU) was used, as proposed for multidetector row CT scan examinations. 7 From the CT scan data analysis, the volume of the segmented lung, the volume of the segmented emphysema, and their ratio (emphysema index, %LAA 2 960), were calculated automatically. The software also divides automatically the inner (core) and outer parts (peel) of lung parenchyma, the latter considered as the lung tissue located within 10 mm of the chest wall. Lung parenchyma was also divided in two parts (upper and lower) for analysis purposes. The upper lung zone was defi ned as those sections above the main carina, and the lower lung zone was defi ned as those sections located below the main carina. The %LAA 2 960 in each region (upper/lower/core/peel) was calculated from the total percentage. Emphysema was classifi ed as upper or lower and core or peel zone predominant.
Statistical Analysis
Variables with normal distribution are described by their mean 6 SD, those with nonnormal distribution with their median and 25th to 50th percentiles, and categorical variables by their The development of software techniques for the analysis of images obtained by CT scanning has enabled researchers to identify and quantify low-attenuation areas (LAA) in vivo that correspond to emphysema. 4 These techniques have been validated with pathologic and functional correlation studies. [5] [6] [7] They have also been applied in different trials to determine if patients with COPD are candidates for lung volume reduction procedures (surgery, biologic glue, endobronchial valves, or radiofrequency-guided bypass procedures) and in a 1 -antitrypsin defi ciency trials to assess response to replacement therapy. [8] [9] [10] COPD is a heterogeneous disease with different phenotypes and with different clinical presentations. 11 The presence of emphysema on CT imaging usually results in a greater degree of severity of COPD. 12 Furthermore, varying distributions of emphysema in the lungs have been associated with different clinical presentations. 13 However, most of the studies that have used CT scan-based software analysis of emphysema have been performed in populations of patients with severe COPD, in which emphysema causes airfl ow limitation through decreased elastic lung recoil and early airway collapse. 3 To our knowledge, there are no data describing the impact of emphysema and its distribution and severity on patients with less severe COPD. It is possible that the mechanisms that cause airfl ow limitation and determine the clinical presentation when the degree of lung parenchyma destruction is mild are different than in more severe disease. The aim of this study was to describe the impact that the presence, distribution, and severity of emphysema has on the clinical presentation of a cohort of patients with mild to moderate COPD (dyspnea, nutritional status, exercise capacity, exacerbation rate, and quality of life).
Materials and Methods
This is a cross-sectional observational study of patients diagnosed with COPD recruited from July 2006 to July 2009 in the pulmonary clinic at the University Clinic of Navarra, a tertiary care medical center. Patients with all degrees of airfl ow limitation were included if they had smoked Ն 20 pack-years and had a postbronchodilator FEV 1 /FVC of , 0.70 after the administration of 400 m g of inhaled albuterol. Individuals were excluded if they had a history of asthma, bronchiectasis, TB, or other confounding diseases. The patients were clinically stable (no exacerbation for at least 2 months) at the time of the evaluation. The study was approved by the institution's ethics committee, and all patients signed an informed consent.
Clinical and Physiologic Evaluation
A personal interview was conducted by trained health-care staff recording age, sex, the presence of signifi cant comorbidities, smoking status, and pack-year history. Spirometry, lung volumes, and diffusing capacity (Vmax 22; Sensormedics Corp; Yorba Table 2 shows the differences found in the clinical parameters between patients with and without emphysema detected by CT scan. Patients with emphysema were older and had higher MMRC scores. As expected, some physiologic parameters (ie, FEV 1 % and D lco ) were worse in patients with emphysema.
The number of women with COPD participating in the study was rather small (only 18), and this precludes a robust sex analysis and comparison between those with and without CT scan-detected emphysema. In any case, the percentage of emphysema tended to be lower in women but was not statistically different than in men (1.14% vs 2.16%, P 5 .07). This may be because of the small number of women in the cohort, which also precludes analysis of differences in emphysema distribution by sex. 
Results
Two hundred thirty-six patients with COPD were included during the study period. We were able to properly register the data and perform the clinical and radiologic evaluation of 200 patients. Of these, 44 subjects were not included in the fi nal cohort because they were found to have bronchiectasis on the chest CT scan. Another 41 patients were excluded because they had advanced-stage COPD (GOLD stages III or IV). Thus, the fi nal study population had 115 patients ( Fig 1 ) , whose clinical and radiologic characteristics are shown in Table 1 . This predominantly male population of patients with mild to moderate COPD with low BODE index scores had normal values of BMI and 6MWD and had a limited expression of the disease as represented by low scores in the MMRC and Saint George Respiratory Questionnaire total scores. The degree of emphysema (% LAA 2 960) was also low, but up to half of the population had radiologically detected emphysema. Emphysema was equally distributed in the upper and lower zones, as well as in core and peel zones. However, severity was greater in the upper and core zones. on the pathophysiology of this disease. Previous data suggest this relationship exists in patients with severe COPD, 13 but, to our knowledge, this association has not been previously reported in patients with mild to moderate disease and low grades of emphysema. Chronic airfl ow limitation can be caused by increased resistance of the small conducting airways and increased compliance of the lung due to emphysema. 2 Traditionally, emphysema is associated with the destruction of alveolar walls, resulting in decreased elastic lung recoil and early airway collapse. 3 It has been estimated that 30% of the lung must be destroyed by emphysema before symptoms or pulmonary function abnormalities become evident. 24 Little is known about the presence and impact of mild emphysema on patients with COPD. In this report, 50% of the patients with COPD included in the study have some degree, albeit low, of CT scan-detected emphysema. In these patients, the physiologic parameters of the disease were worse than in patients without emphysema (ie, lower FEV 1 , higher TLC, and lower D lco ). Despite these differences, the presence of emphysema had no impact on the clinical presentation of patients in this cohort. This is an important fi nding previously reported by others 12, 25 in patients with a greater severity of COPD and emphysema. In our entire cohort, the mean percentage of emphysema was 1.84% (95% CI, 0.76%-4.77%), and even such small degrees of lung destruction affected the physiologic presentation of COPD. It is possible that with such small degrees of emphysema, mechanisms other than changes in elastic recoil may be responsible for the physiologic impairment. As elegantly reported by Boschetto et al, 12 it is possible that patients with COPD who are susceptible to develop emphysema respond differently to inhaled toxic substances, representing a more infl ammatory profi le with physiologic consequences. A recently published work by Clinical and physiologic characteristics of patients with different emphysema distributions (upper/lower/ core/peel) are shown in Figure 2 . Although patients in the four groups have similar age, FEV 1 %, and BMI, they show a great heterogeneity in their physiologic and clinical presentation.
Discussion
CT scan evaluation of patients with COPD allows a more accurate discrimination of the emphysematous phenotype from other presentations of the disease. To our knowledge, this is the fi rst study that describes the presence of emphysema and its association with physiologic and clinical features in patients with mild or moderate COPD. The main fi ndings of the present report support the theory that the presence of emphysema in patients with COPD has an impact Values are presented as mean 6 SD or median (25th-50th percentile) unless otherwise noted. See Table 1 for expansion of abbreviations. that on helical multidetector row CT scan examinations performed using 1.25-mm slices with soft tissue kernel obtained at 80 mAs, lung areas with attenuation coeffi cients , 2 960 or 2 970 HU best refl ect the extent of pulmonary emphysema. 7 Only one study has examined the impact of the distribution of emphysema (upper/lower/core/peel) 13 on the clinical presentation of patients with severe COPD. However, this has not been shown in other degrees of severity. Additionally, the core/peel distribution has not been proven yet to have any clinical or prognostic usefulness in patients with COPD. Mair et al 13 reported that the distribution of emphysema related best to the clinical presentation when divided into core/peel predominance. However, this effect was not independent of the severity of emphysema. In the present study, patients with COPD with mild to moderate disease and mild emphysema have a heterogeneous physiologic and clinical presentation of the disease according to their distribution as shown Papaioannou et al 26 found that patients with CT scandetected emphysema have higher levels of systemic oxidative stress and plasma fi brinogen.
Mair et al 13 analyzed variables that might predict the severity of emphysema and found that BMI was the best predictor. We found no link between severity of emphysema and BMI in our study, perhaps because the severity of emphysema in our cohort was mild. Indeed, although there was an inverse correlation between BMI and areas of low attenuation, individuals with CT scan-detected emphysema did not have lower BMI values. This information could challenge the knowledge that BMI is tightly associated with emphysema, at least in patients with normal BMI and diffuse emphysema. Unfortunately, our cohort included few patients with a low BMI ( , 21), precluding a robust analysis of their degree of emphysema.
We used a three-dimensional automated method to quantify the degree of emphysema. A threshold of 2 960 was chosen based on a recent report showing disease or patients with preserved lung function and emphysema.
Conclusion
In conclusion, in this cohort of patients with mild to moderate COPD, the presence of emphysema, regardless of its distribution, has an impact on physiologic parameters but not on the clinical presentation of the disease. Further studies should confi rm the importance of our fi ndings. in Figure 1 . Although different distributions of emphysema seem to impact presentation heterogeneity, these differences were not statistically signifi cant. Therefore, in mild to moderate COPD, the distribution of emphysema does not have an impact on the clinical presentation of the disease as has been reported in other cohorts with more severe disease. 13 In view of the lack of an effect of emphysema on the clinical presentation in early stages of COPD, it may be argued that the knowledge of its presence is not important. Based on the current study, one could postulate that performing a CT scan in patients with mild or moderate COPD adds little to clinical management. However, we do not know what impact mild degrees of emphysema might have on the natural course of the disease. Furthermore, the presence of emphysema signifi cantly increases the risk of lung cancer in these patients. 27 For this reason alone, we believe that identifying emphysema on a CT scan in patients with COPD is important for their long-term care.
Study Limitations
Small sample size, especially the small number of participating women, is a limitation of this study. It is now well known that there are important sex differences in emphysema severity and distribution. Women have less severe emphysema than men, and it is generally centrally distributed with smaller areas of low attenuation. 28 This limitation precludes an assessment of the role that the presence, severity, and distribution of emphysema might have on the clinical presentation of the disease in women. Knowing that there are consistent sex differences in the clinical presentation of the disease, we believe it is important to further investigate this issue with an appropriate cohort. 29 Only a small percentage of our patients had determinations of a 1 -antitrypsin levels (54 out of 115, 47%), all being within normal limits. However, because only 1% of patients with COPD have a 1 -antitrypsin deficiency, 10 it seems unlikely that more a 1 -antitrypsin determinations would have had a signifi cant impact on the results.
Failure to ensure the achievement of maximal inspiration during scanning (eg, using spirometry in conjunction with the CT scan) may affect the degree of lung attenuation and account for a degree of variability. However, recent data 30 indicate that this technique may not be necessary when performing cross-sectional studies because the reproducibility of patients' inspiratory maneuvers is very high. Finally, because our study population is limited to patients with mild to moderate COPD, these fi ndings cannot be extrapolated either to patients with more severe
